Jayesh Desai

32PUBLICATIONS
257CO-AUTHORS
Molecular targetsAutonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 10, 2026
Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

|Dec 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.

Tejas Patil, Jessica J Lin, Parneet K Cheema

|Oct 19, 2025
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.

Timothy A Yap, David J Kwiatkowski, Ibiayi Dagogo-Jack

|Oct 08, 2025
A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation results.

Jayesh Desai, Sanjeev Deva, Bo Gao

|Jul 09, 2025
Single-Agent Divarasib in Patients With KRAS G12C-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.

Adrian G Sacher, Wilson H Miller, Manish R Patel

|May 30, 2025
Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer.

Elena Elez, Takayuki Yoshino, Lin Shen

Pageof 6

Frequent Collaborators

4 joint publications

Neekesh V Dharia

4 joint publications

Benjamin J Solomon

3 joint publications

Huiling Xu

3 joint publications

Benjamin Markman